Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Liu

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
NPJ Breast Cancer|October 30, 2025
Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancerJenna Bhimani, Kelli O'Connell, Grace B Gallagher, et al.
International Journal of Cancer|July 6, 2024
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancerJenna Bhimani, Kelli O'Connell, Sonia Persaud, et al.
Journal of the National Cancer Institute|November 3, 2025
Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancerErin J Aiello Bowles, Kelli O'Connell, Jenna Bhimani, et al.
JCO Clinical Cancer Informatics|February 14, 2025
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing StudyPeng Wang, Kelli O'Connell, Jenna Bhimani, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2024
Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast CancerJenna Bhimani, Kelli O'Connell, Sonia Persaud, et al.
Breast Cancer Research and Treatment|August 16, 2024
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery systemJenna Bhimani, Kelli O'Connell, Sonia Persaud, et al.
JCO Oncology Practice|December 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast CancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Infection|September 18, 2020
Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptomsXin Li, Jasper Fuk-Woo Chan, Kenneth Kai-Wang Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2011
Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infectionIvan Fn Hung, Kelvin Kw To, Cheuk-Kwong Lee, et al.
Journal of the National Cancer Institute|May 20, 2026
Response to Yu, Wang, and GeYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
NPJ Breast Cancer|October 30, 2025
Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancerJenna Bhimani, Kelli O'Connell, Grace B Gallagher, et al.
International Journal of Cancer|July 6, 2024
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancerJenna Bhimani, Kelli O'Connell, Sonia Persaud, et al.
Journal of the National Cancer Institute|November 3, 2025
Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancerErin J Aiello Bowles, Kelli O'Connell, Jenna Bhimani, et al.
JCO Clinical Cancer Informatics|February 14, 2025
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing StudyPeng Wang, Kelli O'Connell, Jenna Bhimani, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2024
Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast CancerJenna Bhimani, Kelli O'Connell, Sonia Persaud, et al.
Breast Cancer Research and Treatment|August 16, 2024
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery systemJenna Bhimani, Kelli O'Connell, Sonia Persaud, et al.
JCO Oncology Practice|December 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast CancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Infection|September 18, 2020
Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptomsXin Li, Jasper Fuk-Woo Chan, Kenneth Kai-Wang Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2011
Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infectionIvan Fn Hung, Kelvin Kw To, Cheuk-Kwong Lee, et al.
Journal of the National Cancer Institute|May 20, 2026
Response to Yu, Wang, and GeYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Pageof 15